Eleanor Ruth Hastings, MD | |
1 Jarrett White Rd, Tripler Army Medical Center, Tamc, HI 96859-5001 | |
(808) 433-2478 | |
Not Available |
Full Name | Eleanor Ruth Hastings |
---|---|
Gender | Female |
Speciality | Internal Medicine - Hematology & Oncology |
Location | 1 Jarrett White Rd, Tamc, Hawaii |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1578598066 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RH0003X | Internal Medicine - Hematology & Oncology | MD023616 (Tennessee) | Primary |
Mailing Address | Practice Location Address |
---|---|
Eleanor Ruth Hastings, MD 88 Piikoi St, Apt. #2903, Honolulu, HI 96814-4245 Ph: (808) 433-2478 | Eleanor Ruth Hastings, MD 1 Jarrett White Rd, Tripler Army Medical Center, Tamc, HI 96859-5001 Ph: (808) 433-2478 |
News Archive
High cholesterol levels are much more risky for middle-aged men than middle-aged women when it comes to having a first heart attack, a new study of more than 40,000 Norwegian men and women has shown.
With the U.S. Food and Drug Administration's recent approval of transcatheter aortic valve replacement (TAVR) for patients with aortic valvular stenosis, the American College of Cardiology Foundation (ACCF), along with the American Association for Thoracic Surgery (AATS), the Society for Cardiovascular Angiography and Interventions (SCAI) and the Society of Thoracic Surgeons (STS), today released an expert consensus document to provide important guidance on its use.
In the first study of its kind, University of Florida researchers are testing the power of a natural human hormone to biochemically move teeth faster and less painfully during orthodontic treatment.
Genentech, Inc. a wholly-owned member of the Roche Group, and Biogen Idec announced today that the companies received a Complete Response from the U.S. Food and Drug Administration (FDA) for a supplemental Biologics License Application (sBLA) for Rituxan (rituximab) plus methotrexate (MTX) in patients with moderately-to-severely active rheumatoid arthritis (RA) who no longer respond to treatment with a disease modifying antirheumatic drug (DMARD), including MTX.
› Verified 6 days ago
Dr. George Heard Underwood Jr., M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1 Jarrett White Rd, Mchk-im, Tripler Army Medical Center, Tamc, HI 96859 Phone: 808-433-3585 Fax: 808-433-2870 | |
Dr. Jeffrey L Berenberg, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1 Jarrett White Rd, Mchk-dmo, Tamc, Tamc, HI 96859 Phone: 808-433-4089 Fax: 808-433-2707 | |
Dr. Christy Taoka, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1 Jarrett White Rd, Tamc, HI 96859 Phone: 808-433-6641 Fax: 808-433-1555 | |
Dr. Charlene Schambach Mcwilliams, D.O. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1 Jarrett White Rd, Dept Of Internal Medicine, Tamc, HI 96859 Phone: 808-433-5720 | |
Dr. Clarissa Tana Burkert, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center Attn: Mchk-qs, Tamc, HI 96859 Phone: 808-433-2460 Fax: 808-433-1558 | |
Dr. Joseph Sergio Gomes Pina, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center, Tamc, HI 96859 Phone: 808-433-5720 Fax: 808-433-1555 |